Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis

NACompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

December 31, 2012

Study Completion Date

April 30, 2013

Conditions
MalariaPlasmodium Falciparum
Interventions
DRUG

Chloroquine prophylaxis

Standard prophylactic regime: a loading dose of 300 mg on day 14 and day 17 and then 300 mg once a week, starting on day 21, for a total duration of 13 weeks. On day 0, day 3, day 7 and day 10, this group will receive a placebo.

DRUG

Mefloquine prophylaxis

Mefloquine prophylaxis, starting with a loading regime of split doses during the first three weeks: 125 mg on day 0, day 3, day 7, day 10, day 14 and day 17 and 250 mg once a week from day 21 onwards for a total duration of 13 weeks.

BIOLOGICAL

Immunization

Group 1 and 2 will receive three immunizations with Plasmodium falciparum infected mosquito-bites. Group 3 will receive an equal number of uninfected mosquito-bites.

BIOLOGICAL

Controlled Human Malaria Infection

Exposure to the bites of 5 Plasmodium falciparum infected mosquitoes.

DRUG

Malarone

When thick smear positive, of ar day 21 after challenge, all volunteers will be treated with malarone.

Trial Locations (1)

2333 ZA

Leiden University Medical Centre, Leiden

All Listed Sponsors
collaborator

ZonMw: The Netherlands Organisation for Health Research and Development

OTHER

lead

Radboud University Medical Center

OTHER

NCT01422954 - Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine Versus Mefloquine Prophylaxis | Biotech Hunter | Biotech Hunter